RMD Q3 2019 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$662M+11.9% YoY

Gross Profit

$392M59.2% margin

Operating Income

$157M23.7% margin

Net Income

$105M15.9% margin

EPS (Diluted)

$0.73

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

$123M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$4.1B

Total Liabilities

$2.1B

Stockholders' Equity

$2.0B

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$662M	$592M	+11.9%
Gross Profit	$392M	$344M	+13.8%
Operating Income	$157M	$136M	+15.1%
Net Income	$105M	$110M	-4.3%

Revenue Segments

Devices And Masks

$582M88%

Software As Service

$80M12%

Geographic Segments

Global

$662M50%

Us Canada And Latin America

$430M32%

Combined Europe Asia And Other Markets

$232M18%